Evidence map›Paper›PMID 24870409›Full record

ReviewCell cycle (Georgetown, Tex.)2014

The meiosis-specific modification of mammalian telomeres.

Hiroki Shibuya, Yoshinori Watanabe

Open access · bronzeAbstract readReview
In one paragraph

Review in Cell cycle (Georgetown, Tex.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 58 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. mAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Cyclins and CDKs in the regulation of meiosis-specific events.Frontiers in cell and developmental biology · 2022
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Hiroki ShibuyaLaboratory of Chromosome Dynamics; Institute of Molecular and Cellular Biosciences; University of Tokyo; Tokyo, Japan.
Yoshinori WatanabeLaboratory of Chromosome Dynamics; Institute of Molecular and Cellular Biosciences; University of Tokyo; Tokyo, Japan; Graduate School of Agricultural and Life Science; University of Tokyo; Tokyo, Japan.
Chromosome 18 Registry & Research Society · USDivision of Molecular & Cellular Biosciences · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During meiosis, rapid chromosome movements within the nucleus enable homologous chromosomes to acquire physical juxtaposition. In most organisms, chromosome ends, telomeres, tethered to the transmembrane LINC-complex mediate this movement by transmitting cytoskeletal forces to the chromosomes. While the majority of molecular studies have been performed using lower eukaryotes as model systems, recent studies have identified mammalian meiotic telomere regulators, including the LINC-complex SUN1/KASH5 and the meiosis-specific telomere binding protein TERB1. This review highlights the molecular regulations of mammalian meiotic telomeres in comparison with other model systems and discusses some future perspectives.

Indexed as

AnimalsCarrier ProteinsCell Cycle ProteinsChromosomes, MammalianCytoskeletal ProteinsMammalsMeiosisMeiotic Prophase IMicrotubule-Associated ProteinsNuclear ProteinsTelomereCarrier ProteinsCell Cycle ProteinsCytoskeletal ProteinsKASH5 protein, mouseMicrotubule-Associated ProteinsNuclear ProteinsSUN1 protein, mouseTERB1 protein, mousechromosomecohesinmeiosisnuclear envelopetelomere

Identifiers

PMID24870409
PMCPMC4111693
OpenAlexW1982322180

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.